Free tool
FAERS Monitor: Delsym
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018658 or its brand name (Delsym, Dextromethorphan Polistirex). Reports on generic versions are filed under their own applications.
Reports
7,682
Serious
4,053
53% of reports
Hospitalization
1,492
Death reported
1,822
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective1,323
- drug abuse723
- toxicity to various agents693
- overdose599
- dizziness455
- diarrhoea414
- accidental overdose404
- completed suicide352
- death332
- cough313
- nausea293
- dyspnoea255
- no adverse event248
- fatigue247
- vomiting243
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 16 |
| 2005 | 9 |
| 2006 | 33 |
| 2007 | 35 |
| 2008 | 44 |
| 2009 | 52 |
| 2010 | 140 |
| 2011 | 70 |
| 2012 | 147 |
| 2013 | 184 |
| 2014 | 300 |
| 2015 | 1,055 |
| 2016 | 807 |
| 2017 | 749 |
| 2018 | 594 |
| 2019 | 561 |
| 2020 | 575 |
| 2021 | 363 |
| 2022 | 457 |
| 2023 | 476 |
| 2024 | 422 |
| 2025 | 402 |
| 2026 | 191 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,477 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| accidental overdoseSignal | 404 | 30.6 | 27.8 | 11,417 |
| drug abuseSignal | 723 | 24.0 | 22.4 | 15,823 |
| completed suicideSignal | 352 | 11.6 | 10.5 | 3,402 |
| toxicity to various agentsSignal | 693 | 11.3 | 10.5 | 6,517 |
| overdoseSignal | 599 | 7.6 | 7.1 | 3,465 |
| no adverse eventSignal | 248 | 3.8 | 3.3 | 501 |
| coughSignal | 313 | 3.1 | 2.7 | 437 |
| drug ineffectiveSignal | 1,323 | 2.8 | 2.6 | 1,569 |
| dizzinessSignal | 455 | 2.5 | 2.3 | 417 |
| diarrhoea | 414 | 1.8 | 1.6 | 138 |
| vomiting | 243 | 1.4 | 1.3 | 30 |
| dyspnoea | 255 | 1.2 | 1.1 | 11 |
| death | 332 | 1.1 | 0.9 | 1 |
| nausea | 293 | 1.0 | 0.9 | 0 |
| fatigue | 247 | 0.9 | 0.8 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.